全文获取类型
收费全文 | 28577篇 |
免费 | 1473篇 |
国内免费 | 436篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 724篇 |
妇产科学 | 193篇 |
基础医学 | 3113篇 |
口腔科学 | 39篇 |
临床医学 | 3450篇 |
内科学 | 10560篇 |
皮肤病学 | 38篇 |
神经病学 | 790篇 |
特种医学 | 956篇 |
外科学 | 2859篇 |
综合类 | 3682篇 |
预防医学 | 1017篇 |
眼科学 | 15篇 |
药学 | 2062篇 |
13篇 | |
中国医学 | 831篇 |
肿瘤学 | 132篇 |
出版年
2023年 | 361篇 |
2022年 | 608篇 |
2021年 | 851篇 |
2020年 | 803篇 |
2019年 | 1003篇 |
2018年 | 1050篇 |
2017年 | 719篇 |
2016年 | 743篇 |
2015年 | 859篇 |
2014年 | 1993篇 |
2013年 | 1760篇 |
2012年 | 1475篇 |
2011年 | 1866篇 |
2010年 | 1520篇 |
2009年 | 1526篇 |
2008年 | 1615篇 |
2007年 | 1357篇 |
2006年 | 1361篇 |
2005年 | 1211篇 |
2004年 | 926篇 |
2003年 | 784篇 |
2002年 | 597篇 |
2001年 | 573篇 |
2000年 | 529篇 |
1999年 | 391篇 |
1998年 | 294篇 |
1997年 | 304篇 |
1996年 | 243篇 |
1995年 | 264篇 |
1994年 | 215篇 |
1993年 | 179篇 |
1992年 | 199篇 |
1991年 | 158篇 |
1990年 | 117篇 |
1989年 | 127篇 |
1988年 | 135篇 |
1987年 | 109篇 |
1986年 | 87篇 |
1985年 | 123篇 |
1984年 | 132篇 |
1983年 | 106篇 |
1982年 | 117篇 |
1981年 | 118篇 |
1980年 | 138篇 |
1979年 | 108篇 |
1978年 | 100篇 |
1977年 | 94篇 |
1976年 | 86篇 |
1975年 | 98篇 |
1973年 | 86篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
《Journal of Cardiovascular Computed Tomography》2020,14(5):407-413
BackgroundCT measurement of supra-annular area (SA) has been proposed as an alternative to annular area (AA) for sizing of trancatheter valves in biscuspid aortic valves (BAV). This study examines the reproducibility of SA and AA measurements and their potential impact on downstream transcatheter heart valve sizing and clinical outcomes.Methods44 consecutive patients (mean age: 73 ± 15 years, 57% male) undergoing CTA with subsequent SAPIEN 3 valve insertion for severe bicuspid aortic stenosis (AS) were included. AA was measured at the basal ring. SA was measured by generating a circle defined by the intercommisural distance. AA and SA were measured by 2 independent observers. Baseline characteristics, TAVR procedural data, and discharge echocardiography data were collected.ResultsThe SA was significantly larger than the AA (562 ± 146mm2 vs. 518 ± 112mm2,p = 0.013). Interobserver agreement was high using both techniques (ICC AA = 0.98,p < 0.001; SA = 0.80,p < 0.001), but with narrower limits of agreement with AA measurements (mean difference (limits of agreement): AA = −3mm2 (22; 19), SA = −16mm2 (−92; 76)). AA-based device sizing demonstrated substantial agreement with final valve inserted (κ = 0.72,p < 0.001), while SA demonstrated fair agreement (κ = 0.40,p < 0.001). There was no difference in post TAVR gradients, paravalvular leakage or valve success between patients with concordant sizing between AA and SA, and those in whom SA would have suggested an alternate valve size.ConclusionsSupra-annular sizing is less reproducible than annular sizing, with no difference in procedural complication rates in patients in whom supra-annular sizing would have altered the device size used. These results suggest no role for supra-annular sizing in current clinical practice. 相似文献
92.
93.
Previous studies have demonstrated that targeting inflammation is a promising strategy for treating lipopolysaccharide (LPS)-induced sepsis and related heart injury. Interleukin-35 (IL-35), which consists of two subunits, Epstein–Barr virus-induced gene 3 (EBI3) and p35, is an immunosuppressive cytokine of the IL-12 family and exhibits strong anti-inflammatory activity. However, the role of IL-35 in LPS-induced heart injury reains obscure. In this study, we explored the role of IL-35 in heart injury induced by LPS and its potential mechanisms. Mice were treated with a plasmid encoding IL-35 (pIL-35) and then injected intraperitoneally (ip) with LPS (10 mg/kg). Cardiac function was assessed by echocardiography 12 h later. LPS apparently decreased the expression of EBI3 and p35 and caused cardiac dysfunction and pathological changes, which were significantly improved by pIL-35 pretreatment. Moreover, pIL-35 pretreatment significantly decreased the levels of cardiac proinflammatory cytokines including TNF-α, IL-6, and IL-1β, and the NLRP3 inflammasome. Furthermore, decreased number of apoptotic myocardial cells, increased BCL-2 levels and decreased BAX levels inhibited apoptosis, and LPS-induced upregulation of the expression of cardiac pro-fibrotic genes (MMP2 and MMP9) and fibrotic factor (Collagen type I) was inhibited. Further investigation indicated that pIL-35 pretreatment might suppressed the activation of the cardiac NF-κBp65 and TGF-β1/Smad2/3 signaling pathways in LPS-treated mice. Similar cardioprotective effects of IL-35 pretreatment were observed in mouse myocardial fibroblasts challenged with LPS in vitro. In summary, IL-35 pretreatment can attenuate cardiac inflammation, apoptosis, and fibrotic reactions induced by LPS, implicating IL-35 as a promising therapeutic target in sepsis-related cardiac injury. 相似文献
94.
95.
96.
97.
98.
99.
100.
《Gaceta sanitaria / S.E.S.P.A.S》2016,30(3):191-200
ObjectiveTo identify the factors associated with prolonged length of hospital stay in patients admitted for acute heart failure.MethodsMultipurpose observational cohort study including patients from the EAHFE registry admitted for acute heart failure in 25 Spanish hospitals. Data were collected on demographic and clinical variables and on the day and place of admission. The primary outcome was length of hospital stay longer than the median.ResultsWe included 2,400 patients with a mean age of 79.5 (9.9) years; of these, 1,334 (55.6%) were women. Five hundred and ninety (24.6%) were admitted to the short stay unit (SSU), 606 (25.2%) to cardiology, and 1,204 (50.2%) to internal medicine or gerontology. The mean length of hospital stay was 7.0 (RIC 4-11) days. Fifty-eight (2.4%) patients died and 562 (23.9%) were readmitted within 30 days after discharge. The factors associated with prolonged length of hospital stay were chronic pulmonary disease; being a device carrier; having an unknown or uncommon triggering factor; the presence of renal insufficiency, hyponatremia and anaemia in the emergency department; not being admitted to an SSU or the lack of this facility in the hospital; and being admitted on Monday, Tuesday or Wednesday. The factors associated with length of hospital stay≤7days were hypertension, having a hypertensive episode, or a lack of treatment adherence. The area under the curve of the mixed model adjusted to the center was 0.78 (95% CI: 0.76-0.80; p < 0.001).ConclusionsA series of factors is associated with prolonged length of hospital stay and should be taken into account in the management of acute heart failure. 相似文献